Effects of l-Serine on Macrolide Resistance in Streptococcus suis

Tong Wu1,2, Xiaozhen Wang1,2, Yue Dong1,2

  • 1College of Veterinary Medicine, Northeast Agricultural University, Harbin, Heilongjiang, China.

Microbiology Spectrum
|July 22, 2022
PubMed

Insights

Supplementing L-serine can restore macrolide effectiveness against drug-resistant Streptococcus suis by reactivating the serine catabolic pathway. This approach combats antimicrobial resistance by targeting bacterial metabolism and increasing reactive oxygen species.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Streptococcus suis is a significant zoonotic pathogen causing health threats in humans and animals.
  • Widespread macrolide use has led to high-level drug resistance in S. suis, necessitating alternative therapeutic strategies.
  • Developing new antibacterial drugs is time-consuming and resource-intensive.

Purpose of the Study:

  • To investigate the potential of targeting bacterial metabolic pathways to overcome macrolide resistance in S. suis.
  • To explore how L-serine supplementation can restore the susceptibility of S. suis to macrolides.
  • To elucidate the molecular mechanisms by which L-serine impacts bacterial physiology and drug sensitivity.

Main Methods:

  • Untargeted metabolomics analysis to identify metabolic alterations in drug-resistant S. suis.
  • In vitro and in vivo experiments to assess the effect of L-serine on macrolide efficacy.
  • Analysis of intracellular metabolites, reactive oxygen species (ROS) levels, and DNA damage.

Main Results:

  • Drug-resistant S. suis exhibited an inhibited serine catabolic pathway.
  • L-serine addition restored macrolide fungicidal activity by enhancing the serine metabolic pathway.
  • L-serine inhibited H2S and Fe-S cluster production, normalized the Fenton reaction, and reduced glutathione, leading to increased ROS and DNA damage.

Conclusions:

  • L-serine supplementation represents a promising strategy to restore macrolide sensitivity in drug-resistant S. suis.
  • Targeting the serine catabolic pathway offers a novel approach to combat antimicrobial resistance.
  • This study provides a theoretical basis for rational macrolide use and identifies a potential target for resensitizing S. suis to existing antibiotics.